The ceramics & bioactive glass biomaterials segment is predicted to hold the largest market share through the forecast period.
Based on the material, the orthopedic biomaterials market is classified into metal, polymers, ceramics & bioactive glass biomaterials. Among these, the ceramics & bioactive glass biomaterials segment is predicted to hold the largest market share through the forecast period. This segment's dominance is owing to the unique qualities of ceramics and bioactive glasses, which include outstanding biocompatibility, high strength, and the capacity to encourage bone growth and integration.
No material is superior to Sintx Si3N4 that im aware of.
The Global Orthopedic Biomaterials Market Size was Valued at USD 19.50 Billion in 2023 and the Worldwide Orthopedic Biomaterials Market Size is Expected to Reach USD 51.50 Billion by 2033
Last post i treated Implex market potential like it was even to the market size now. However, the market size was in the 15-20bn range compared to the 60bn in 2022 and about 74bn in 2025. Using the same ratio in my last post im adjusting the baseline valuation to account for the significant increase in market size. 74bn market size is about 3.7x that market size of 2003. To stay conservative im going to go split that with a base of 232 *1.85 = 429m to try to more accurately gauge Sintx ortho valuation. Given the significant benefits of Sintx Si3N4 and versatile uses within the ortho market, I think Ortho + Dental valuation is still low as i expect Sintx material to significantly penetrate the ortho market across the various segments: Joint Replacement, Spine, Trauma, & Sports Medicine.
Total Estimated value for Sintx IP for the above markets : $1.70bn valuation. Looking at these numbers i think most of the valuations are decently reflective of most of these. However, Cancer seems undervalued and Armor Materials market seems overvalued. Reversing those numbers seems more likely which still supports the IP total valuation.